$1.71
-0.06-3.39%
At close: -
$1.73
0.021.14%
After Hours: 7:30 PM EDT
IGM Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of IGM Biosciences using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-08 | $-1.01 | $-0.80 | -26.3 % |
Q2 | 2024-08-14 | $-0.79 | $-0.04 | -1875.0 % |
Q1 | 2024-05-08 | $-0.83 | $-0.83 | 0.00 % |
Q4 | 2024-03-07 | $-1.01 | $-1.03 | 1.94 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-08 | $516.00K | $270.00K | 91.1 % |
Q2 | 2024-08-14 | $1.25M | $54.31M | -97.7 % |
Q1 | 2024-05-08 | $497.00K | $760.00K | -34.6 % |
Q4 | 2024-03-07 | $651.00K | $700.00K | -7.00 % |
IGM Biosciences (IGMS) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
The Actual EPS was $-1.01, which missed the estimate of $-0.80.
The Actual Revenue was $516K, which beat the estimate of $270K.
Browse earnings estimates, EPS, and revenue on all stocks.